|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 434.96 USD | +1.20% |
|
+1.41% | -3.85% |
| Capitalization | 109B 92.57B 84.78B 79.94B 149B 10,394B 150B 1,005B 392B 4,950B 409B 401B 17,130B | P/E ratio 2026 * |
24.6x | P/E ratio 2027 * | 21.7x |
|---|---|---|---|---|---|
| Enterprise value | 94.71B 80.37B 73.61B 69.4B 129B 9,024B 130B 873B 341B 4,298B 355B 348B 14,872B | EV / Sales 2026 * |
7.26x | EV / Sales 2027 * | 6.31x |
| Free-Float |
99.79% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Vertex Pharmaceuticals Incorporated
| 1 day | +1.85% | ||
| 1 week | +1.52% | ||
| Current month | +2.11% | ||
| 1 month | -0.83% | ||
| 3 months | -5.39% | ||
| 6 months | +1.67% | ||
| Current year | -3.74% |
| 1 week | 412.27 |  | 442.16 |
| 1 month | 412.27 | | 447.82 |
| Current year | 412.27 | | 507.92 |
| 1 year | 362.5 | | 507.92 |
| 3 years | 320.01 | | 519.88 |
| 5 years | 176.36 | | 519.88 |
| 10 years | 71.46 | | 519.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 2020-03-31 | |
Charles Wagner
DFI | Director of Finance/CFO | 58 | 2019-04-09 |
Mark Bunnage
CTO | Chief Tech/Sci/R&D Officer | - | 2021-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Sachs
BRD | Director/Board Member | 66 | 1997-12-31 |
Jeffrey Leiden
CHM | Chairman | 70 | 2012-04-30 |
Sangeeta Bhatia
BRD | Director/Board Member | 57 | 2015-06-17 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -.--% | 2.32% | 2 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.88% | +1.52% | -0.68% | +24.54% | 109B | |
| +2.55% | +0.53% | +28.79% | +123.42% | 846B | |
| +0.04% | -1.36% | +43.47% | +37.36% | 533B | |
| +0.75% | -2.50% | +6.78% | +38.45% | 356B | |
| +1.21% | -0.97% | +22.40% | +12.53% | 324B | |
| +1.18% | +1.29% | +31.44% | +13.23% | 282B | |
| +0.30% | -0.12% | +24.02% | +22.81% | 278B | |
| +1.04% | -0.66% | +39.71% | -4.41% | 275B | |
| +3.34% | +6.03% | -32.03% | -48.08% | 203B | |
| -0.72% | +1.52% | +19.66% | +41.53% | 179B | |
| Average | +1.19% | -0.47% | +18.35% | +26.14% | 338.45B | |
| Weighted average by Cap. | +1.28% | -1.08% | +23.81% | +44.69% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13.04B 11.06B 10.13B 9.55B 17.82B 1,242B 17.96B 120B 46.9B 592B 48.92B 47.89B 2,047B | 14.28B 12.12B 11.1B 10.46B 19.52B 1,361B 19.68B 132B 51.38B 648B 53.58B 52.46B 2,243B |
| Net income | 4.44B 3.77B 3.45B 3.26B 6.07B 423B 6.12B 40.96B 15.99B 202B 16.67B 16.32B 698B | 5.07B 4.3B 3.94B 3.72B 6.93B 483B 6.99B 46.75B 18.25B 230B 19.03B 18.63B 796B |
| Net Debt | -14.38B -12.2B -11.17B -10.53B -19.65B -1,370B -19.81B -133B -51.72B -652B -53.94B -52.81B -2,258B | -19.02B -16.14B -14.78B -13.94B -26B -1,812B -26.21B -175B -68.44B -863B -71.38B -69.88B -2,987B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-05-11 | 435.87 $ | +1.41% | 620,855 |
| 26-05-08 | 429.82 $ | +1.13% | 953,348 |
| 26-05-07 | 425.00 $ | -0.62% | 1,112,655 |
| 26-05-06 | 427.65 $ | +0.78% | 1,203,285 |
| 26-05-05 | 424.36 $ | -1.28% | 1,906,343 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- VRTX Stock
Select your edition
All financial news and data tailored to specific country editions
